4//SEC Filing
Lev Pharmaceuticals Inc 4
Accession 0001144204-06-025482
CIK 0001144062operating
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 5:11 PM ET
Size
6.0 KB
Accession
0001144204-06-025482
Insider Transaction Report
Form 4
SCHEIN JOSHUA D
DirectorCEO10% Owner
Transactions
- Purchase
Common Stock
2006-06-19$0.60/sh+2,500$1,500→ 1,000,505 total
Holdings
- 27,473,417(indirect: see footnote)
Common Stock
Footnotes (1)
- [F1]Consists of shares of common stock owned by Prism Ventures, LLC, a limited liability company in which Mr. Schein owns a 50% interest, and the following entities, all of which are owned by Prism Ventures, LLC: Newton Partners, LLC, Windsor Ventures, LLC, Sapphire Ventures, LLC, Tudor Technology Ventures, LLC and Entry Point Capital LLC.
Documents
Issuer
Lev Pharmaceuticals Inc
CIK 0001144062
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001144062
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 5:11 PM ET
- Size
- 6.0 KB